Home » ENANTA PHARMACEUTICALS ACHIEVES MILESTONE IN ALLIANCE WITH SHIONOGI & CO., LTD.
ENANTA PHARMACEUTICALS ACHIEVES MILESTONE IN ALLIANCE WITH SHIONOGI & CO., LTD.
Enanta Pharmaceuticals today announced that it has received a milestone payment from its East Asia development and commercialization partner, Shionogi & Co., Ltd., as Phase 2 studies have initiated in Japan for its community antibiotic, EDP-420 (formerly known as EP-013420, and known in Japan as S-013420).
Yahoo News (http://biz.yahoo.com/prnews/051220/netu018.html?.v=39)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May